OGN

Organon & Co.

18.55 USD
+0.02 (+0.11%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Organon & Co. stock is up 14.01% since 30 days ago. The dividend yield is 6.85% and its next earnings date is May 2, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 66.67% of the previous 2 February’s closed higher than January. In the last 10 Unusual Options Trades, there were 10 CALLs. 0% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
15 Feb 14:51 15 Mar, 2024 17.50 CALL 432 1864
15 Feb 15:41 19 Apr, 2024 15.00 CALL 100 10608
16 Feb 14:38 16 Feb, 2024 17.50 CALL 200 1869
16 Feb 17:37 19 Apr, 2024 15.00 CALL 350 10552
21 Feb 14:30 17 Jan, 2025 12.50 CALL 200 810
21 Feb 17:30 15 Mar, 2024 17.50 CALL 471 2937
21 Feb 18:10 15 Mar, 2024 17.50 CALL 500 2937
22 Feb 15:04 17 Jan, 2025 10.00 CALL 40 512
22 Feb 15:38 15 Mar, 2024 17.50 CALL 500 2645
22 Feb 16:41 16 Jan, 2026 12.50 CALL 72 245

About Organon & Co.

Organon & Co. develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. It also offers cardiovascular products, consisting of several cholesterol-modifying medicines. The company sells its products primarily to drug wholesalers and retailers, hospitals, and government agencies.